ESSA Pharma Inc (EPIX)
6.34
-0.38
(-5.65%)
USD |
NASDAQ |
Apr 19, 16:00
6.34
0.00 (0.00%)
After-Hours: 18:20
ESSA Pharma Total Liabilities (Quarterly): 3.806M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.806M |
| September 30, 2023 | 3.495M |
| June 30, 2023 | 3.408M |
| March 31, 2023 | 2.166M |
| December 31, 2022 | 2.983M |
| September 30, 2022 | 2.387M |
| June 30, 2022 | 4.145M |
| March 31, 2022 | 3.894M |
| December 31, 2021 | 3.947M |
| September 30, 2021 | 4.160M |
| June 30, 2021 | 3.826M |
| March 31, 2021 | 4.593M |
| December 31, 2020 | 2.074M |
| September 30, 2020 | 1.331M |
| June 30, 2020 | 1.352M |
| March 31, 2020 | 1.517M |
| December 31, 2019 | 1.334M |
| September 30, 2019 | 5.591M |
| June 30, 2019 | 6.453M |
| Date | Value |
|---|---|
| March 31, 2019 | 5.948M |
| December 31, 2018 | 6.437M |
| September 30, 2018 | 6.865M |
| June 30, 2018 | 7.574M |
| March 31, 2018 | 8.960M |
| December 31, 2017 | 9.751M |
| September 30, 2017 | 9.881M |
| June 30, 2017 | 10.58M |
| March 31, 2017 | 19.64M |
| December 31, 2016 | 14.51M |
| September 30, 2016 | 10.94M |
| June 30, 2016 | 10.40M |
| March 31, 2016 | 10.59M |
| December 31, 2015 | 3.954M |
| September 30, 2015 | 3.084M |
| June 30, 2015 | 3.407M |
| March 31, 2015 | 2.052M |
| December 31, 2014 | 0.9716M |
| September 30, 2014 | 2.228M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.331M
Minimum
Sep 2020
6.453M
Maximum
Jun 2019
3.288M
Average
3.495M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 144.49M |
| Shareholders Equity (Quarterly) | 140.68M |